The Significance of Liquid Biopsy in Pancreatic Cancer

被引：43

作者：

Qi, Zi-Hao ^{[1
,2
,3
,4
]}

Xu, Hua-Xiang ^{[1
,2
,3
,4
]}

Zhang, Shi-Rong ^{[1
,2
,3
,4
]}

Xu, Jin-Zhi ^{[1
,2
,3
,4
]}

Li, Shuo ^{[1
,2
,3
,4
]}

Gao, He-Li ^{[1
,2
,3
,4
]}

Jin, Wei ^{[1
,2
,3
,4
]}

Wang, Wen-Quan ^{[1
,2
,3
,4
]}

Wu, Chun-Tao ^{[1
,2
,3
,4
]}

Ni, Quan-Xing ^{[1
,2
,3
,4
]}

Yu, Xian-Jun ^{[1
,2
,3
,4
]}

Liu, Liang ^{[1
,2
,3
,4
]}

机构：

[1] Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R China

[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China

[3] Shanghai Pancreat Canc Inst, Shanghai 200032, Peoples R China

[4] Fudan Univ, Pancreat Canc Inst, Shanghai 200032, Peoples R China

来源：

JOURNAL OF CANCER | 2018年 / 9卷 / 18期

基金：

美国国家科学基金会;

关键词：

Circulating tumor cells; Cell-free nucleic acid; Exosomes; Liquid biopsy; Pancreatic cancer; CIRCULATING TUMOR-CELLS; NUCLEIC-ACIDS; FREE DNA; DISEASE PROGRESSION; EDUCATED PLATELETS; CLINICAL-RELEVANCE; PAN-CANCER; SERUM DNA; BIOMARKER; EXOSOMES;

D O I：

10.7150/jca.24591

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal types of cancer. The 5-year survival rate for PDAC remains low because it is always diagnosed at an advanced stage and it is resistant to therapy. A biomarker, which could detect asymptomatic premalignant or early malignant tumors and predict the response to treatment, will benefit patients with PDAC. However, traditional biopsy has its limitations. There is an urgent need for a tumor biomarker that could easily and repeatedly sample and monitor, in real time, the progress of tumor development. Liquid biopsy could be a tool to assess potential biomarkers. In this review, we focused on the latest discoveries and advancements of liquid biopsy technology in pancreatic cancer research and demonstrated how this technology is being used in clinical applications.

引用

页码：3417 / 3426

页数：10

共 50 条

[31] Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma
Osei-Bordom, Daniel C.
Sachdeva, Gagandeep
Christou, Niki
FRONTIERS IN MEDICINE, 2022, 8
[32] Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation
Kangchun Wang
Xin Wang
Qi Pan
Bei Zhao
Molecular Cancer, 22
[33] The systematic role of pancreatic cancer exosomes: distant communication, liquid biopsy and future therapy
Qin, Cheng
Li, Tianyu
Lin, Chen
Zhao, Bangbo
Li, Zeru
Zhao, Yutong
Wang, Weibin
CANCER CELL INTERNATIONAL, 2024, 24 (01)
[34] Liquid Biopsy in Oral Cancer
Lousada-Fernandez, Fatima
Rapado-Gonzalez, Oscar
Lopez-Cedrun, Jose-Luis
Lopez-Lopez, Rafael
Muinelo-Romay, Laura
Mercedes Suarez-Cunqueiro, Maria
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (06)
[35] Liquid biopsy in colorectal cancer
Najafi, Sajad
Majidpoor, Jamal
Mortezaee, Keywan
CLINICA CHIMICA ACTA, 2024, 553
[36] Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer
Jang, Albert
Rauterkus, Grant P.
Vaishampayan, Ulka N.
Barata, Pedro C.
ONCOTARGETS AND THERAPY, 2022, 15 : 897 - 912
[37] Advances in liquid biopsy on-chip for cancer management: Technologies, biomarkers, and clinical analysis
Tadimety, Amogha
Closson, Andrew
Li, Cathy
Yi, Song
Shen, Ting
Zhang, John X. J.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2018, 55 (03) : 140 - 162
[38] Circulating tumor cells in pancreatic cancer: more than liquid biopsy
Li, Zeru
Qin, Cheng
Zhao, Bangbo
Li, Tianyu
Zhao, Yutong
Zhang, Xiangyu
Wang, Weibin
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
[39] Liquid biopsy for precision diagnostics and therapeutics
Anitha, Kuttiappan
Posinasetty, Bhargavi
Kumari, K. Naveen
Chenchula, Santenna
Padmavathi, R.
Prakash, Satya
Radhika, Chikatipalli
CLINICA CHIMICA ACTA, 2024, 554
[40] Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms
Smolkova, Bozena
Kataki, Agapi
Earl, Julie
Ruz-Caracuel, Ignacio
Cihova, Marina
Urbanova, Maria
Buocikova, Verona
Tamargo, Sandra
Rovite, Vita
Niedra, Helvijs
Schrader, Joerg
Kohl, Yvonne
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 180

← 1 2 3 4 5 →